Company intelligence / Profile preview

Celleration

Eden Prairie, Minnesota, United States

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Celleration’s MIST Therapy System is a commercialized, FDA-cleared wound care device that uses painless, noncontact low-frequency ultrasound delivered through a saline mist to accelerate healing in acute and chronic wounds. Clinical evidence includes over 19 peer-reviewed publications with randomized controlled trials and meta-analysis supporting efficacy. The system has been used more than 1.2 million times on over 85,000 patients.

Therapeutic areas: OtherDermatology
Modalities: DeviceNon-pharmacological therapyUltrasound-based therapy
Industry: Therapeutic Medical Devices

Partnerships

No major pharma/biotech partnerships disclosed prior to acquisition.

Beyond the preview

Go deeper on Celleration.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celleration.

Explore the full profile